Financials

  • Market Capitalization 1.77 B
  • Employee 130
  • Founded 2019
  • CEO N/A
  • Website www.septerna.com
  • Headquarter Delaware, United States
  • FIGI BBG014WY1V28
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-25.35
Fiyat/satışlar oranı
26.85

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
2023
ZYME
Zymeworks Inc. - Common Stock
25.13 USD-0.79%-2.75%-6.23%+41.66%1.78 B USD
2024
TRVI
Trevi Therapeutics, Inc. - Common Stock
12.50 USD-3.33%-5.37%-21.88%+30.89%1.78 B USD
2032
SRPT
Sarepta Therapeutics, Inc. - Common Stock
16.70 USD-4.24%-3.19%-18.73%-22.61%1.76 B USD
2037
MRVI
Maravai LifeSciences Holdings, Inc. - Class A common stock
6.71 USD-4.96%-19.35%+2.76%+109.03%1.74 B USD